LONG FOCUS CAPITAL MANAGEMENT, LLC Iovance Biotherapeutics, Inc. Transaction History

LONG FOCUS CAPITAL MANAGEMENT, LLC portfolio value:

$8.96M
portfolio value

LONG FOCUS CAPITAL MANAGEMENT, LLC quarter portfolio value change:

-13.22%
quarter

Iovance Biotherapeutics, Inc. 13F transactions

Quarter Transaction type Change Relative change Absolute change Change value Avg. price Shares
Q3 2022 share Decrease -42.40% -689K shares -8.97M $9.58 936K
Q2 2022 share Increase +130.50% 920K shares 6.20M $11.04 1.62M
Q1 2022 share Increase +34.29% 180K shares 1.71M $16.65 705K
Q4 2021 share Increase 0.00% 525K shares 10.02M $19.42 525K